Atlas Trials

Syndax Pharmaceuticals

30 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch Syndax Pharmaceuticals

RecordFirmDate
A Study of SNDX-5613 in Combination With Intensive Chemotherapy in Participants With Acute Myeloid Leukemias (NCT06226571)Syndax Pharmaceuticals2024-05-21
MAXPIRe: Study to Evaluate Axatilimab in Participants With Idiopathic Pulmonary Fibrosis (IPF) (NCT06132256)Syndax Pharmaceuticals2023-12-11
Evaluation of Revumenib in Participants With Colorectal Cancer and Other Solid Tumors (NCT05731947)Syndax Pharmaceuticals2023-04-04
Study of Radiolabeled Revumenib in Adults With Acute Leukemia (NCT05406817)Syndax Pharmaceuticals2022-08-05
A Study of Revumenib in Combination With Chemotherapy in Participants With R/R Acute Leukemia (NCT05326516)Syndax Pharmaceuticals2022-03-09
A Study of Axatilimab at 3 Different Doses in Participants With Chronic Graft Versus Host Disease (cGVHD) (NCT04710576)Syndax Pharmaceuticals2021-03-04
A Phase 2 Study to Evaluate Axatilimab for Hospitalized Participants With Respiratory Involvement Secondary to COVID-19 (NCT04415073)Syndax Pharmaceuticals2020-05-30
A Study of Revumenib in R/R Leukemias Including Those With an MLL/KMT2A Gene Rearrangement or NPM1 Mutation (NCT04065399)Syndax Pharmaceuticals2019-11-05
A Phase 1/2 Study to Evaluate Axatilimab in Participants With Active cGVHD (NCT03604692)Syndax Pharmaceuticals2018-11-01
A Phase 1 Study to Investigate Axatilimab Alone or in Combination With Durvalumab in Patients With Solid Tumors (NCT03238027)Syndax Pharmaceuticals2017-09-01

Track Syndax Pharmaceuticals automatically

Every clearance here is in the API, with alerts when new ones post.